Remove any of those pieces and youre guessing
AAPS Pharmscitech 12 (1), 337343 (2011)
FOXO4-DRI is a synthetic senolytic peptide developed to selectively target and eliminate senescent cells, often referred to as "zombie cells." These dysfunctional cells accumulate with aging and are associated with chronic inflammation, tissue degeneration, and age-related decline
It is also only one piece of a much larger aging network that includes genomic instability, mitochondrial dysfunction, chronic inflammation, epigenetic changes, altered nutrient sensing, and cellular senescence
Conclusion: Semaglutide with B12 to counter energy loss for your weight loss journey Semaglutide is a GLP-1 receptor agonist that facilitates weight loss by delaying gastric emptying and reducing appetite, along with a low-calorie diet and physical exercise